-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KcthBFKttKUdazSJHAiSA0k1AeL7eItnUTna61jcybtsf92UlbZNZ7Q4GVpBtir5 UQ9SMlb36f9cBd9W8YFPjg== 0000812796-07-000026.txt : 20070314 0000812796-07-000026.hdr.sgml : 20070314 20070314144341 ACCESSION NUMBER: 0000812796-07-000026 CONFORMED SUBMISSION TYPE: AW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070314 DATE AS OF CHANGE: 20070314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: AW SEC ACT: SEC FILE NUMBER: 333-133975 FILM NUMBER: 07693342 BUSINESS ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 AW 1 withdrawalsb2.htm WITHDRAWAL SB2 PRE EFFECTIVE
 


March 14, 2007
 
Via EDGAR
 
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C.20549
 
Re:       DOR BioPharma, Inc.
            Withdrawal of PRE-EFFECTIVE AMENDMENT NO. 1 TO THE REGISTRATION STATEMENT on FORM SB-2

            SEC File No. 333-133975
 
Ladies and Gentlemen:
 
            In accordance with Rule 477 of Regulation C promulgated under the Securities Act of 1933, as amended, DOR BioPharma, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests the immediate withdrawal of the above-referenced Pre-Effective Amendment No. 1 to the Registration Statement on Form SB-2 (SEC File No. 333-133975) filed on March 12, 2007.
 
            The Registrant is making this request because the Registrant inadvertently filed a Form SB-2/A pre-effective amendment filing when it should have filed a POS AM post-effective amendment.  The Registrant filed on March 13, 2007 the appropriate Post-Effective Amendment No. 1 to the Registration Statement on Form SB-2 as a POS AM post-effective amendment.
 
            We appreciate your assistance and should you need any additional information, please feel free to contact the undersigned at (786) 425-3848.
 
 
 
 
 
Respectfully submitted,
 
 
DOR BIOPHARMA, INC.
 
 
 
 
 
 
 
By:  
/s/ James Clavijo
 
 
James Clavijo
 
Treasurer and Secretary

-----END PRIVACY-ENHANCED MESSAGE-----